Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
209 SEK | -1.42% | -9.79% | +4.43% |
Mar. 13 | Probi AB Strengthens Its Brand Position and Expands in the Nordics | CI |
Jan. 26 | Transcript : Probi AB, Q4 2023 Earnings Call, Jan 26, 2024 |
Business Summary
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Probiotics
98.5
%
| 643 | 97.7 % | 609 | 98.5 % | -5.23% |
Royalties
1.5
%
| 15 | 2.3 % | 9 | 1.5 % | -40.70% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
72.5
%
| 478 | 72.6 % | 448 | 72.5 % | -6.20% |
EMEA, excluding Sweden
11.9
%
| 85 | 12.9 % | 74 | 11.9 % | -12.86% |
Asia Pacific
8.8
%
| 49 | 7.5 % | 54 | 8.8 % | +9.51% |
Sweden
5.8
%
| 39 | 6.0 % | 36 | 5.8 % | -9.34% |
Americas excluding United States
1.0
%
| 7 | 1.0 % | 6 | 1.0 % | -6.31% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anita Johansen
CEO | Chief Executive Officer | - | 22-03-31 |
Director of Finance/CFO | 58 | Oct. 31 | |
Von Carlson
COO | Chief Operating Officer | 54 | 23-02-28 |
Niklas Larsson
CTO | Chief Tech/Sci/R&D Officer | 54 | 07-12-31 |
Jörn Andreas
BRD | Director/Board Member | 44 | 13-12-31 |
Human Resources Officer | 41 | 19-12-31 | |
Shane Judge
SAM | Sales & Marketing | 56 | 19-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 53 | 20-05-12 | |
Chairman | 60 | 15-03-31 | |
Director/Board Member | 62 | 17-05-03 | |
Jörn Andreas
BRD | Director/Board Member | 44 | 13-12-31 |
Director/Board Member | 66 | 18-05-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,394,125 | 3,175,771 ( 27.87 %) | 0 | 27.87 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Probi USA, Inc.
Probi USA, Inc. BiotechnologyHealth Technology Probi USA, Inc. provides research and develops patents probiotic strains for use in nutritional products. The company was founded on September 22, 2016 and is headquartered in Redmond, WA. |
Biotechnology
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.43% | 231M | |
+30.83% | 687B | |
+31.36% | 595B | |
+0.01% | 378B | |
+15.18% | 316B | |
+11.39% | 308B | |
+0.47% | 211B | |
-5.85% | 208B | |
-3.70% | 203B | |
-3.72% | 157B |
- Stock
- Equities
- Stock Probi AB - Nasdaq Stockholm
- Company Probi AB